Betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment — RxCUI 388525
RxNorm drug concept · Semantic clinical drug
RxCUI 388525
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI388525
Official nameBetamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment; calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment; betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment; betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment
FDA products mapped5
Package NDCs mapped8
Reported Medicaid activity (SDUD)2,444 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Calcipotriene Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Calcipotriene is not a steroid at all — it's a synthetic form of vitamin D3. While steroid creams work by suppressing inflammation, calcipotriene is thought to work by binding to v...
- What exactly is calcipotriene, and how is it different from a steroid cream?
- No — calcipotriene should not be applied to the face. The label is clear on this for all product forms. If you have psoriasis on your face, talk to your dermatologist about other o...
- Can I use this on my face if my psoriasis is there too?
🕸️ Concept Web — How Betamethasone 0.0005 MG/MG / calcipotriene 0.000... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment
RxCUI 388525 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Betamethasone
1514IN -
Calcipotriene
29365IN -
Betamethasone / calcipotriene
690419MIN
-
Betamethasone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Taclonex
748281BN
-
Taclonex
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Betamethasone / calcipotriene Topical Ointment
393355SCDF -
Betamethasone / calcipotriene Topical Product
1153789SCDG -
Betamethasone / calcipotriene Topical Ointment [Taclonex]
748283SBDF -
Taclonex Topical Product
1177831SBDG -
Topical Ointment
316985DF -
Topical Product
1151122DFG
-
Betamethasone / calcipotriene Topical Ointment
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Betamethasone 0.0005 MG/MG
330632SCDC -
Calcipotriene 0.00005 MG/MG
329613SCDC -
Betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [Taclonex]
833472SBD -
Betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG [Taclonex]
833471SBDC
-
Betamethasone 0.0005 MG/MG
Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Betamethasone 0.0005 MG/MG
SCDC · 330632 -
Calcipotriene 0.00005 MG/MG
SCDC · 329613 -
Betamethasone / calcipotriene Topical Ointment
SCDF · 393355 -
Betamethasone / calcipotriene Topical Product
SCDG · 1153789
Brand-Name Concepts
-
Betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [Taclonex]
SBD · 833472 -
Betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG [Taclonex]
SBDC · 833471 -
Betamethasone / calcipotriene Topical Ointment [Taclonex]
SBDF · 748283 -
Taclonex Topical Product
SBDG · 1177831 -
Taclonex
BN · 748281
📦 FDA Products & Package NDCs
5 products · 8 package NDCs
8 package NDCs map to RxCUI 388525 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 45802-0816-01 | 1 TUBE in 1 CARTON (45802-816-01) / 100 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Padagis Israel Pharmaceuticals Ltd | 2020-01-30 |
| 45802-0816-96 | 1 TUBE in 1 CARTON (45802-816-96) / 60 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Padagis Israel Pharmaceuticals Ltd | 2020-01-30 |
| 63629-2520-01 | 1 TUBE in 1 CARTON (63629-2520-1) / 60 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Bryant Ranch Prepack | 2020-01-30 |
| 63629-8617-01 | 1 TUBE in 1 CARTON (63629-8617-1) / 100 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Bryant Ranch Prepack | 2020-01-30 |
| 66993-0938-61 | 1 TUBE in 1 CARTON (66993-938-61) / 60 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Prasco Laboratories | 2020-01-28 |
| 66993-0938-65 | 1 TUBE in 1 CARTON (66993-938-65) / 100 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Prasco Laboratories | 2020-01-28 |
| 72162-1428-01 | 1 TUBE in 1 CARTON (72162-1428-1) / 100 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Bryant Ranch Prepack | 2023-12-05 |
| 72162-1428-06 | 1 TUBE in 1 CARTON (72162-1428-6) / 60 g in 1 TUBE | Calcipotriene and Betamethasone Dipropionate | Bryant Ranch Prepack | 2023-12-05 |
Observed labelers:
Bryant Ranch Prepack (4) ·
Padagis Israel Pharmaceuticals Ltd (2) ·
Prasco Laboratories (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.